2KI4

FGF1-S100A13 complex structure: key component in non-classical path way of FGF1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
2	2D 1H-13C HSQC	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
3	3D HNCO	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
4	3D HNCA	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
5	3D CBCA(CO)NH	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
6	3D HBHA(CO)NH	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
7	3D HCCH-TOCSY	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
8	3D 1H-15N NOESY	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298
9	3D 1H-13C NOESY	1.2 mM [U-100% 13C; U-100% 15N] entity_1-1, 1.2 mM [U-100% 13C; U-100% 15N] entity_2-2, entity_3-3	90% H2O/10% D2O	0.1	6.0	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	Avance	800
2	Bruker	Avance	600

NMR Refinement
Method	Details	Software
simulated annealing	ARIA/CNS HADDOCK	ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	5000
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	ARIA	1.2 & 2.2	Linge, O'Donoghue and Nilges
2	chemical shift assignment	SPARKY		Goddard
3	peak picking	SPARKY		Goddard
4	structure solution	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
5	refinement	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
6	collection	TOPSPIN		Bruker Biospin
7	processing	TOPSPIN		Bruker Biospin

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.